Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, Solara Active Pharma Sciences has informed that the Company, as part of investors engagement activities, has scheduled a conference call with the investors and analysts on Wednesday, August 4, 2021 to discuss its Q1 financial results. The conference call details are as enclosed.
The above information is a part of company’s filings submitted to BSE.